Citrine Medicine is a pharmaceutical company and focused on providing effective and affordable therapeutic solutions to rare disease patients in the Greater China. Citrine Medicine currently focuses on 4 therapeutic areas: neurology, endocrinology, liver, kidney & metabolic diseases, and rare oncology. Citrine already has two assets WAKIX^® & Alkindi^® in pre-NDA stage for rare diseases in neurology and endocrinology, respectively.

Zircon Health is a Health technology company aiming to build the largest patient-centered open ecological service platform in China with the help of cutting-edge technology. Zircon Health will leverage Internet digital tools, big data, and artificial intelligence technologies to improve the awareness of rare diseases, promote disease screening and diagnosis, carry out full-cycle disease management, and explore various payment innovations, providing comprehensive and one-stop health service solutions for patients and families affected by rare diseases.

Vision
To become the LEADING company supporting the rare disease community in China.

Mission
To provide individuals and families in China affected by rare diseases with ACCESS to the BEST, most effective medicines, and treatment protocols available in the world.

Approach
Building the FIRST rare disease ecosystem in China to bring a support network and much-needed treatments to individuals and their families affected by rare disease.

RareStone Group training

RareStone - Online AI Training